Combination therapy of urogenital embryonal rhabdomyosarcoma in children Academic Article Article uri icon

Overview

MeSH Major

  • DNA Methylation
  • Exons
  • Gene Silencing
  • Transcription, Genetic

abstract

  • Twenty‐seven children with embryonal rhabdomyosarcoma of the urogenital tract were treated between 1960‐1971. A review of their courses reveals that early stage of the disease at the time of diagnosis and multidisciplinary therapy —surgery, radiotherapy, and multiple drug therapy—offer the best chance for prolonged survival and cure. Seventeen (63%) of the 27 children are living and have been free of the tumor for 18 months‐10 years. Copyright © 1973 American Cancer Society

publication date

  • January 1973

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(197311)32:5<1178::AID-CNCR2820320526>3.0.CO;2-6

PubMed ID

  • 4757910

Additional Document Info

start page

  • 1178

end page

  • 85

volume

  • 32

number

  • 5